James Mulay
Director, Fulgent Genetics.
Companies
- CG Oncology, Inc.Board member Jan 24, 2024 to now1
- Fulgent GeneticsBoard member Sep 28, 2016 to Jun 3, 20192
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- CG Oncology, Inc. CGON0 shares3Jul 10, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 10, 2026Sold 24,165 shares at $75.16 of CG Oncology, Inc.3
- Jul 10, 2026Exercised options 24,165 shares at $26.63 of CG Oncology, Inc.3
- Jun 15, 2026Sold 1,310 shares at $60.12 of CG Oncology, Inc.4
- Jun 15, 2026Exercised options 1,310 shares at $12.59 of CG Oncology, Inc.4
- Jun 15, 2026Sold 654 shares at $60.12 of CG Oncology, Inc.4
- Jun 15, 2026Exercised options 654 shares at $3.72 of CG Oncology, Inc.4
- Apr 17, 2026Sold 15,600 shares at $73.01 of CG Oncology, Inc.5
- Apr 17, 2026Exercised options 15,600 shares at $36.63 of CG Oncology, Inc.5
- Mar 16, 2026Sold 1,310 shares at $63.50 of CG Oncology, Inc.6
- Mar 16, 2026Exercised options 1,310 shares at $12.59 of CG Oncology, Inc.6
- Mar 16, 2026Sold 654 shares at $63.50 of CG Oncology, Inc.6
- Mar 16, 2026Exercised options 654 shares at $3.72 of CG Oncology, Inc.6
- Jan 9, 2026Sold 10,491 shares at $52.99 of CG Oncology, Inc.7
- Jan 9, 2026Exercised options 10,491 shares at $12.59 of CG Oncology, Inc.7
- Jan 9, 2026Sold 654 shares at $44.16 of CG Oncology, Inc.7
- Jan 9, 2026Exercised options 654 shares at $3.72 of CG Oncology, Inc.7
- Oct 9, 2025Sold 5,903 shares at $43.99 of CG Oncology, Inc.8
- Oct 9, 2025Exercised options 5,903 shares at $3.72 of CG Oncology, Inc.8
- Sep 29, 2025Sold 12,755 shares at $39.19 of CG Oncology, Inc.9
- Sep 29, 2025Exercised options 12,755 shares at $1.82 of CG Oncology, Inc.9
- Sep 19, 2025Sold 3,574 shares at $38.99 of CG Oncology, Inc.10
- Sep 19, 2025Exercised options 3,574 shares at $1.82 of CG Oncology, Inc.10
- Sep 18, 2025Sold 19,112 shares at $39.01 of CG Oncology, Inc.10
- Sep 18, 2025Exercised options 19,112 shares at $1.82 of CG Oncology, Inc.10
- Sep 5, 2025Sold 3,113 shares at $33.22 of CG Oncology, Inc.11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARCG Oncology, Inc., Board member
- 2SEC EDGARFulgent Genetics, Board member
- 3
- 4SEC EDGARForm 4 filed Jun 16, 2026
- 5SEC EDGARForm 4 filed Apr 20, 2026
- 6SEC EDGARForm 4 filed Mar 17, 2026
- 7SEC EDGARForm 4 filed Jan 13, 2026
- 8SEC EDGARForm 4 filed Oct 10, 2025
- 9SEC EDGARForm 4 filed Sep 30, 2025
- 10SEC EDGARForm 4 filed Sep 22, 2025
- 11SEC EDGARForm 4 filed Sep 8, 2025